348 related articles for article (PubMed ID: 24895506)
21. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Tumor Burden Assessed by Dual Time Point [
Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
[TBL] [Abstract][Full Text] [Related]
23. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer].
Tang B; Zhang Y; Zhou J; Xu Y; Li TR; Ding CY
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):280-285. PubMed ID: 28550668
[No Abstract] [Full Text] [Related]
25. Predictive value of
Başoğlu T; Özgüven S; Özkan HŞ; Çınar M; Köstek O; Demircan NC; Arıkan R; Telli TA; Ercelep Ö; Kaya H; Öneş T; Erdil TY; Uğurlu MÜ; Dane F; Yumuk PF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(3):171-178. PubMed ID: 35577492
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
[TBL] [Abstract][Full Text] [Related]
27. Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis.
Arslan E; Can Trabulus D; Mermut Ö; Şavlı TC; Çermik TF
J Med Imaging Radiat Oncol; 2021 Feb; 65(1):38-45. PubMed ID: 33084216
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative
Hwang SH; Jung M; Jeong YH; Jo K; Kim S; Wang J; Cho A
Cancer Metab; 2021 Jan; 9(1):8. PubMed ID: 33509304
[TBL] [Abstract][Full Text] [Related]
29. [
Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
[TBL] [Abstract][Full Text] [Related]
30. 18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients.
Bai L; Guo C; Wang J; Liu X; Li Y; Li M; Guo Y; Duan X
Onco Targets Ther; 2016; 9():6315-6324. PubMed ID: 27789962
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
33. Different
El-Hennawy G; Moustafa H; Omar W; Elkinaai N; Kamel A; Zaki I; Farid N; El-Kholy E
Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
[TBL] [Abstract][Full Text] [Related]
34. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Hori M; Onishi H; Tsuboyama T; Nakamoto A; Ota T; Eguchi H; Wakasa K; Hatazawa J; Tomiyama N
Eur J Radiol; 2017 Sep; 94():64-69. PubMed ID: 28712692
[TBL] [Abstract][Full Text] [Related]
35. The Role of Pretreatment
Yao J; Wang Y; Lin Y; Yang Y; Wan J; Gong X; Zhang F; Zhang W; Marks T; Wang S; Jin H; Shan H
Drug Des Devel Ther; 2021; 15():4157-4166. PubMed ID: 34621120
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of baseline
Reyes Marlés RH; Navarro Fernández JL; Puertas García-Sandoval JP; Santonja Medina F; Mohamed Salem L; Frutos Esteban L; Contreras Gutiérrez JF; Castellón Sánchez MI; Ruiz Merino G; Claver Valderas MA
Eur J Hybrid Imaging; 2021 Sep; 5(1):16. PubMed ID: 34476632
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
[TBL] [Abstract][Full Text] [Related]
38. The Use of
Hlongwa KN; Mokoala KMG; Matsena-Zingoni Z; Vorster M; Sathekge MM
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328148
[TBL] [Abstract][Full Text] [Related]
39. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
[TBL] [Abstract][Full Text] [Related]
40. Baseline [
Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]